Home » Newsletters » BioWorld Science

BioWorld Science

March 1, 1999

View Archived Issues

Palatin awarded 4th and 5th SBIR grants for MIDAS technology

Schering-Plough initiates manufacture of Vasomax

Positive ribavirin study results reported in the Journal of Hepatology

Spotlight update: fibrinogen (gpIIb/IIIa) receptor antagonists

Atrix expands drug delivery patent portfolio

Antiplatelet agents under research at Monsanto

Potent nAChR receptor agonists with heterocyclic structure patented by Astra

Magainin awarded SBIR grant for squalamine

New joint venture will invest in Australian life sciences and medical technologies

Novo Nordisk discloses new potassium channel modulators and use in endocrine and other disorders

French investigators describe potent and selective dopamine D3 agonists

Lilly introduces new insulin dosing forms with improved convenience

Merck & Co.'s new thrombin inhibitors

FDA advisory committee to review another NDA for Temodal in March

Placebo-controlled study supports the efficacy of Alrex in seasonal allergic conjunctivitis

Clinical trial shows HP-3 effective in COPD

Immunomedics' new immunotoxin against CEA is first in its class

Valspodar plus chemotherapy in the treatment of relapsed or refractory AML

Medarex reacquires worldwide rights to MDX-210

DSRB recommends continuation of Bextra study

Botulinum toxin compared to pneumatic dilatation in patients with achalasia

Licensing opportunity from BTG: antiasthmatic compound with a novel mechanism of action

Photofrin approved in Finland

Small pilot study demonstrates efficacy and safety of IL-2 with concomitant antiretroviral therapy

European CPMP recommends approval of Integrilin for acute coronary syndrome

European authorities okay merger of Astra and Zeneca

PPL's initial results of AAT trial in cystic fibrosis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...